首页> 外文期刊>Journal of Translational Medicine >First confirmatory study on PTPRQ as an autosomal dominant non-syndromic hearing loss gene
【24h】

First confirmatory study on PTPRQ as an autosomal dominant non-syndromic hearing loss gene

机译:PTPRQ作为常染色体显性非综合征性听力损失基因的首次验证性研究

获取原文
获取外文期刊封面目录资料

摘要

Biallelic PTPRQ pathogenic variants have been previously reported as causative for autosomal recessive non-syndromic hearing loss. In 2018 the first heterozygous PTPRQ variant has been implicated in the development of autosomal dominant non-syndromic hearing loss (ADNSHL) in a German family. The study presented the only, so far known, PTPRQ pathogenic variant (c.6881GA) in ADNSHL. It is located in the last PTPRQ coding exon and introduces a premature stop codon (p.Trp2294*). A five-generation Polish family with ADNSHL was recruited for the study (n?=?14). Thorough audiological, neurotological and imaging studies were carried out to precisely define the phenotype. Genomic DNA was isolated from peripheral blood samples or buccal swabs of available family members. Clinical exome sequencing was conducted for the proband. Family segregation analysis of the identified variants was performed using Sanger sequencing. Single nucleotide polymorphism array on DNA samples from the Polish and the original German family was used for genome-wide linkage analysis. Combining clinical exome sequencing and family segregation analysis, we have identified the same (NM_001145026.2:c.6881GA, NP_001138498.1:p.Trp2294*) PTPRQ alteration in the Polish ADNSHL family. Using genome-wide linkage analysis, we found that the studied family and the original German family derive from a common ancestor. Deep phenotyping of the affected individuals showed that in contrast to the recessive form, the PTPRQ-related ADNSHL is not associated with vestibular dysfunction. In both families ADNSHL was progressive, affected mainly high frequencies and had a variable age of onset. Our data provide the first confirmation of PTPRQ involvement in ADNSHL. The finding strongly reinforces the inclusion of PTPRQ to the small set of genes leading to both autosomal recessive and dominant hearing loss.
机译:先前已报道双等位基因PTPRQ致病变异是常染色体隐性非综合征性听力损失的病因。 2018年,第一个杂合的PTPRQ变异体与德国家庭常染色体显性非综合征性听力损失(ADNSHL)的发展有关。该研究提出了迄今为止唯一已知的ADNSHL中的PTPRQ致病变异(c.6881G> A)。它位于最后一个PTPRQ编码外显子中,并引入了过早的终止密码子(p.Trp2294 *)。该研究招募了一个具有ADNSHL的五代波兰家庭(n = 14)。进行了透彻的听力学,神经病学和影像学研究以精确定义表型。从外周血样本或可获得的家庭成员的口腔拭子中分离基因组DNA。对先证者进行了临床外显子组测序。使用Sanger测序对鉴定出的变体进行家族分离分析。来自波兰和原始德国家族的DNA样品上的单核苷酸多态性阵列用于全基因组连锁分析。结合临床外显子组测序和家族分离分析,我们在波兰人ADNSHL家族中鉴定出相同的(NM_001145026.2:c.6881G> A,NP_001138498.1:p.Trp2294 *)PTPRQ改变。使用全基因组连锁分析,我们发现被研究的家族和原始的德国家族来自一个共同的祖先。受影响个体的深表型表明,与隐性形式相反,PTPRQ相关的ADNSHL与前庭功能障碍无关。在这两个家族中,ADNSHL都是进行性的,主要受高频影响并且发病年龄可变。我们的数据首次证实了PTPRQ参与ADNSHL。这一发现强烈地加强了将PTPRQ纳入少数基因,从而导致常染色体隐性和显性听力损失。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号